Conversely, the SPDR S&P Biotech ETF displays more volatility, like high-beta stocks.
"History suggests that while S&P is likely to continue rallying from here, high beta will not continue to outperform to the same degree," said Chintan Kotecha, an analyst at BAML, in a note to clients. The same up-then-down pattern has historically occurred within the biotech sector, and provides a way for traders to profit from a likely slowdown in high-beta stocks, Kotecha said.
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
Watch TD Bank CEO and Visa president discuss the future of financeTop executives at TD Bank, Visa and online small-business-lending firm OnDeck will discuss the future of finance. Looks like we are ending the federal reserve
ادامه مطلب »
Stocks making the biggest moves midday: Deutsche Bank, Nielsen, Movado & moreThese are the stocks posting the largest moves midday Thursday. Deutsche Bank - Strong buy!
ادامه مطلب »